Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03663816 · ClinicalTrials.gov registry record · NA

Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking

A NA study of Balance, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT03663816: Completed NA study of Balance, sponsored by University of Florida.

NCT03663816 is a NA study of Balance that has completed, run by University of Florida. The registered enrollment target is 15 participants, below the 113-participant average among 7 other Balance trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03663816, a NA study of Balance, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

This study involves the use of a newly designed shoe insole device (also referred to as a foot insole device) similar to various shoe insoles or inserts you can buy at a store or pharmacy.

Primary Outcome

Two-foot stance, Single foot balance, and Tandem stance- Once the data are collected, calculations of center of mass displacement (in cm) will be determined. These values will provide insight about direction of sway and how quickly sway occurs during these three balance conditions.

Conditions Studied

Interventions

  • DEVICE experimental foot device

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2018-10-01
Est. Completion 2019-03-15
Phase NA
University of Florida

1,106 total trials

What the finished NCT03663816 record still lists

NCT03663816 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 113-participant average among 7 other Balance trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Balance appearing as the primary indexed condition, and to 1 intervention - of which experimental foot device is the first listed.

NCT03663816 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03663816 about?

NCT03663816 is a clinical study titled "Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking". This study involves the use of a newly designed shoe insole device (also referred to as a foot insole device) similar to various shoe insoles or inserts you can buy at a store or pharmacy.

What is the current status of trial NCT03663816?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-10-01. Estimated completion is 2019-03-15.

What conditions does trial NCT03663816 study?

This clinical trial studies the following conditions: Balance.

What interventions are being tested in trial NCT03663816?

The interventions under investigation include: experimental foot device (DEVICE).

Who is sponsoring clinical trial NCT03663816?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03663816 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Balance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03663816, the US trial registry maintained by the National Library of Medicine. NCT03663816 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.